Monograph Details
|
|
Pain & Pyrexia
> Topical analgesics/anesthetics
|
|
XYLOCAINE VISCOUS |
| Manufacturer |
|
AstraZeneca Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Topical anesthetic. |
| Generic Name |
|
Lidocaine 2%; viscous soln. |
| Also |
• XYLOCAINE JELLY
• XYLOCAINE OINTMENT
• XYLOCAINE TOPICAL SOLN
|
| Indications |
|
Anesthesia of oropharygeal mucosa. |
| Children |
|
<3yrs: 1.25mL every 3 hrs applied with cotton swab; max 8 doses/day. ≥3yrs: individualize. |
| Adults |
|
15mL every 3 hrs as a gargle or mouthwash (may swallow); max 8 doses/day. |
| Precautions |
|
Sepsis. Traumatized mucosa. Severe shock. Heart block. Monitor for familial malignant hyperthermia (eg, tachycardia, tachypnea). Avoid eyes. Do not eat for 1 hour after oral application. Children, elderly, debilitated, acutely ill: reduce dose. Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
CNS effects (eg, dizziness, visual disturbances, tremor, respiratory depression), bradycardia, hypotension. |
| How Supplied |
Jelly—5 mL, 10 mL, 20 mL, 30 mL
Viscous—100 mL, 450 mL
Oint—3.5 g, 35 g
Soln—50 mL |
|
|
|
|
